Clinical outcomes with drug-eluting stents, bare-metal stents, and bioresorbable scaffolds implanted in patients with AMI treated with primary PCI. Data from the Prague-18 trial
2021
-
Correction
-
Source
-
Cite
-
Save
0
References
0
Citations
NaN
KQI